MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential

T. A. Williams, P. Longati, L. Pugliese, P. Gual, A. Bardelli, P. Michieli

Research output: Contribution to journalArticlepeer-review

Abstract

Ron and Met are structurally related receptor tyrosine kinases that elicit a complex biological response leading to invasive growth. Naturally occurring point mutations activate the Met kinase in papillary renal carcinomas (MET(PRC) mutations). By site-directed mutagenesis, we generated homologous amino acid substitutions in the Ron kinase domain and analyzed the biochemical and biological properties of the mutant receptors. Among the mutations studied, D1232H and M1254T displayed transforming activity in NIH3T3 cells, inducing focus formation and anchorage-independent growth. The D1232H and M1254T substitutions resulted in increased Ron autophosphorylation both in vivo and in vitro and constitutive binding to intracellular signal transducers. Both mutations yielded a dramatic increase in catalytic efficiency, indicating a direct correlation between kinase activity and oncogenic potential. Molecular modeling of the Ron D1232H mutation suggests that this single amino acid substitution favors the transition of the kinase from the inactive to the active state. These data demonstrate that point mutations can confer transforming activity to the Ron receptor and show that RON is a potential oncogene.

Original languageEnglish
Pages (from-to)507-514
Number of pages8
JournalJournal of Cellular Physiology
Volume181
Issue number3
DOIs
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Fingerprint Dive into the research topics of 'MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential'. Together they form a unique fingerprint.

Cite this